Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / SHS USD
-
Total 13F shares
-
52,654,654
-
Share change
-
-1,890,048
-
Total reported value
-
$8,685,222,791
-
Put/Call ratio
-
42%
-
Price per share
-
$165.05
-
Number of holders
-
428
-
Value change
-
-$294,935,573
-
Number of buys
-
185
-
Number of sells
-
200
Institutional Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q4 2020
As of 31 Dec 2020,
Jazz Pharmaceuticals plc - SHS USD (JAZZ) was held by
428 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
52,654,654 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, FMR LLC, LSV ASSET MANAGEMENT, STATE STREET CORP, JPMORGAN CHASE & CO, AQR CAPITAL MANAGEMENT LLC, Boston Partners, and CITADEL ADVISORS LLC.
This page lists
429
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.